Tempus AI (TEM) Is One Of The Best Healthcare Mid-Cap AI Stock According To Analysts

Tempus AI’s exertion present has the quality to place erstwhile a diligent receiving a modular cause is expected to bash poorly. This volition not lone assistance cause companies plan smarter objective trials but besides assistance doctors instrumentality amended attraction decisions arsenic aboriginal arsenic possible. The company’s banal has mislaid one-fifth of its worth successful a month, which is understandable, fixed that astir analysts lowered their terms targets successful May. However, with the occurrence of its sequencing platform, further revisions could travel successful the short-term, prompting a rally successful the stock, which is already up 8% successful the past 5 trading days.

Tempus AI Inc. (NASDAQ:TEM) is simply a healthcare exertion institution that uses artificial quality to beforehand precision medicine. It achieves this done its monolithic libraries of objective and genomic data. Pharmaceutical companies usage their products to amended cause find processes portion physicians usage them to personalize treatments for their patients. The steadfast is based successful Chicago, United States.

While we admit the imaginable of TEM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Mid-Cap AI Stocks to Buy According to Analysts and 7 Best Data Centre GPU-as-a-Service Stocks To Buy.

Disclosure: None. Follow Insider Monkey connected Google News.